Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (4654)
Nurix Therapeutics, Inc. (NRIX)
van Houte Hans — Chief Financial Officer
Shares
2,967
Price
$24.65
Total Value
$73.13K
Shares Held After
40,166
% of Holdings
6.9%
Nurix Therapeutics, Inc. (NRIX)
van Houte Hans — Chief Financial Officer
Shares
1,794
Price
$23.89
Total Value
$42.86K
Shares Held After
43,133
% of Holdings
4.0%
GENELUX Corp (GNLX)
Yu Yong — Chief Scientific Officer
Shares
653
Price
$2.94
Total Value
$1.92K
Shares Held After
268,371
% of Holdings
0.2%
GENELUX Corp (GNLX)
Cappello Joseph — Chief Technical Officer
Shares
653
Price
$2.95
Total Value
$1.92K
Shares Held After
328,737
% of Holdings
0.2%
GENELUX Corp (GNLX)
Zindrick Thomas — President and CEO
Shares
3,023
Price
$2.95
Total Value
$8.91K
Shares Held After
1,260,890
% of Holdings
0.2%
Imunon, Inc. (IMNN)
Eylward Susan — General Counsel and Corp Sec
Shares
2,541
Price
$1.57
Total Value
$3.98K
Shares Held After
2,896
% of Holdings
46.7%
MapLight Therapeutics, Inc. (MPLT)
Lillie James Woodruff — Chief Scientific Officer
Shares
22,082
Price
$12.54
Total Value
$276.91K
Shares Held After
202,380
% of Holdings
9.8%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
409
Price
$292.82
Total Value
$119.76K
Shares Held After
41,514
% of Holdings
1.0%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
991
Price
$291.71
Total Value
$289.09K
Shares Held After
41,923
% of Holdings
2.3%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
200
Price
$290.60
Total Value
$58.12K
Shares Held After
42,914
% of Holdings
0.5%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
503
Price
$289.80
Total Value
$145.77K
Shares Held After
43,114
% of Holdings
1.2%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
356
Price
$288.75
Total Value
$102.79K
Shares Held After
43,617
% of Holdings
0.8%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
1,214
Price
$287.77
Total Value
$349.36K
Shares Held After
43,973
% of Holdings
2.7%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
1,032
Price
$286.80
Total Value
$295.97K
Shares Held After
45,187
% of Holdings
2.2%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
157
Price
$285.74
Total Value
$44.86K
Shares Held After
46,219
% of Holdings
0.3%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
33
Price
$284.55
Total Value
$9.39K
Shares Held After
46,376
% of Holdings
0.1%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
105
Price
$284.14
Total Value
$29.83K
Shares Held After
46,409
% of Holdings
0.2%
GILEAD SCIENCES, INC. (GILD)
O'Day Daniel Patrick — Director
Shares
600
Price
$131.34
Total Value
$78.81K
Shares Held After
592,133
% of Holdings
0.1%
GILEAD SCIENCES, INC. (GILD)
O'Day Daniel Patrick — Director
Shares
7,700
Price
$130.80
Total Value
$1.01M
Shares Held After
592,733
% of Holdings
1.3%
GILEAD SCIENCES, INC. (GILD)
O'Day Daniel Patrick — Director
Shares
6,700
Price
$129.66
Total Value
$868.71K
Shares Held After
600,433
% of Holdings
1.1%
Simulations Plus, Inc. (SLP)
DiBella John Anthony II — Chief Revenue Officer
Shares
1,000
Price
$18.28
Total Value
$18.28K
Shares Held After
85,140
% of Holdings
1.2%
Xeris Biopharma Holdings, Inc. (XERS)
McCulloch Kevin — President and Chief Operating Officer
Shares
15,000
Price
$8.02
Total Value
$120.24K
Shares Held After
1,676,126
% of Holdings
0.9%
Xeris Biopharma Holdings, Inc. (XERS)
Hecht Beth — Chief Legal Officer and Corporate Secretary
Shares
16,666
Price
$8.01
Total Value
$133.55K
Shares Held After
1,144,462
% of Holdings
1.4%
Orchestra BioMed Holdings, Inc. (OBIO)
Sherman Darren — Director
Shares
15,000
Price
$4.09
Total Value
$61.35K
Shares Held After
1,154,327
% of Holdings
1.3%
DEXCOM INC (DXCM)
FOLETTA MARK G — Director
Shares
2,000
Price
$85.32
Total Value
$170.64K
Shares Held After
48,852
% of Holdings
3.9%
4D Molecular Therapeutics, Inc. (FDMT)
Kirn David — Director
Shares
12,415
Price
$10.05
Total Value
$124.72K
Shares Held After
871,737
% of Holdings
1.4%
IQVIA HOLDINGS INC. (IQV)
STAUB W RICHARD — President, Research&Development Solutions Power of Attorney
Shares
5,500
Price
$232.68
Total Value
$1.28M
Shares Held After
13,312
% of Holdings
29.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
320
Price
$518.61
Total Value
$165.96K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,220
Price
$517.49
Total Value
$631.33K
Shares Held After
324,763
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,075
Price
$516.49
Total Value
$1.07M
Shares Held After
325,983
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
4,218
Price
$515.73
Total Value
$2.18M
Shares Held After
328,058
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,667
Price
$514.83
Total Value
$858.23K
Shares Held After
332,276
% of Holdings
0.5%
CASTLE BIOSCIENCES INC (CSTL)
Juvenal Tobin W — Chief Commercial Officer
Shares
1,730
Price
$28.25
Total Value
$48.87K
Shares Held After
78,995
% of Holdings
2.1%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
3,597
Price
$30.35
Total Value
$109.18K
Shares Held After
27,009
% of Holdings
11.8%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
4,232
Price
$30.35
Total Value
$128.45K
Shares Held After
31,781
% of Holdings
11.8%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
10,664
Price
$30.35
Total Value
$323.68K
Shares Held After
21,479
% of Holdings
33.2%
iRhythm Holdings, Inc. (IRTC)
Smith Mervin — EVP Strategic Business Ops
Shares
617
Price
$122.12
Total Value
$75.35K
Shares Held After
22,410
% of Holdings
2.7%
INCYTE CORP (INCY)
Mayes Patrick A — EVP&Chief Scientific Officer
Shares
6,055
Price
$120.43
Total Value
$729.20K
Shares Held After
61,441
% of Holdings
9.0%
iRhythm Holdings, Inc. (IRTC)
Rodda Julianne — EVP, CHIEF PEOPLE OFFICER
Shares
2,112
Price
$122.12
Total Value
$257.92K
Shares Held After
18,201
% of Holdings
10.4%
iRhythm Holdings, Inc. (IRTC)
Patterson Chad — CHIEF COMM&PRODUCT OFFICER
Shares
2,712
Price
$122.12
Total Value
$331.19K
Shares Held After
55,629
% of Holdings
4.6%
FENNEC PHARMACEUTICALS INC. (FENC)
Raykov Rosty — Former Director
Shares
10,000
Price
$9.58
Total Value
$95.80K
Shares Held After
131,633
% of Holdings
7.1%
Ultragenyx Pharmaceutical Inc. (RARE)
Horn Howard — Chief Financial Officer
Shares
4,696
Price
$24.92
Total Value
$117.02K
Shares Held After
96,295
% of Holdings
4.6%
Ultragenyx Pharmaceutical Inc. (RARE)
Parschauer Karah Herdman — EVP and Chief Legal Officer
Shares
1,900
Price
$24.92
Total Value
$47.35K
Shares Held After
92,562
% of Holdings
2.0%
APTARGROUP, INC. (ATR)
Tanda Stephan B. — Director
Shares
9,838
Price
$136.16
Total Value
$1.34M
Shares Held After
238,729
% of Holdings
4.0%
CHEMED CORP (CHE)
MCNAMARA KEVIN J — Director
Shares
2,000
Price
$539.51
Total Value
$1.08M
Shares Held After
70,418
% of Holdings
2.8%
Anteris Technologies Global Corp. (AVR)
L1 Capital Pty Ltd — 10% Owner
Shares
475,693
Price
$8.10
Total Value
$3.85M
Shares Held After
6,108,910
% of Holdings
7.2%
APTARGROUP, INC. (ATR)
Tlili Hedi — Segment President
Shares
8,854
Price
$135.00
Total Value
$1.20M
Shares Held After
15,379
% of Holdings
36.5%
Alkermes plc. (ALKS)
snyderman nancy lynn MD — Director
Shares
44,472
Price
$50.35
Total Value
$2.24M
Shares Held After
15,395
% of Holdings
74.3%
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)
Umberger Traci S — Director
Shares
7,590
Price
$23.86
Total Value
$181.06K
Shares Held After
199,405
% of Holdings
3.7%
Alkermes plc. (ALKS)
Gaffin David Joseph — EVP, CLO, Alkermes, Inc.
Shares
2,034
Price
$48.58
Total Value
$98.81K
Shares Held After
225,456
% of Holdings
0.9%
Showing 1–50 of 4654 transactions (page 1 of 94)